Skip to main content
Clinical Trials/NCT01812941
NCT01812941
Unknown
Not Applicable

Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients

University of South Alabama1 site in 1 country50 target enrollmentSeptember 2011
ConditionsBurnsTrauma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Burns
Sponsor
University of South Alabama
Enrollment
50
Locations
1
Primary Endpoint
Plasma mtDNA DAMPs concentration
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this project is to evaluate the level of mitochondrial dysfunction several patient populations: Burn, trauma, and control group of healthy volunteers.

Study hypothesis: Increased plasma concentrations of a newly discovered inflammatory mediated, called mtDNA DAMPS associated with the occurrence of multi-organ dysfunction syndrome in severly injured patients.

As the severity of a burn injury or trauma injury increase, so will systemic mitochondrial dysfunction.

Detailed Description

Increased plasma concentrations of a newly discovered inflammatory mediated, called mtDNA DAMPS associated with the occurrence of multi-organ dysfunction syndrome in severly injured patients. A normal healthy sub-population will be used as a control.

Registry
clinicaltrials.gov
Start Date
September 2011
End Date
December 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jon Simmons

Principal investigator

University of South Alabama

Eligibility Criteria

Inclusion Criteria

  • Burn injury must be less than 24 hours old at time of initial sampling
  • Burn must be 2nd or 3rd degree and at least 10% TBSA
  • ISS (injury severity score) \> 15

Exclusion Criteria

  • Burn injury/trauma injury \> than 24hours old at time of initial sampling
  • Burn \< 10% total body surface area.
  • Evidence of active infection on admission in the burn subjects.
  • \< 19 years of age and \> 70 years

Outcomes

Primary Outcomes

Plasma mtDNA DAMPs concentration

Time Frame: approximately 1 year to assess outcome measure

Plasma mtDNA DAMPs concentration

Study Sites (1)

Loading locations...

Similar Trials